Who we help

Men's health patients

For the 35–55 man seeking regenerative treatment for ED or fertility, privately.

For Men's health patients
A calm, private EU clinical setting.

Men's-health conditions have different causes and established treatment pathways. A cell or extracellular-vesicle product should not be described as addressing a root cause without condition- and product-specific evidence.

How to evaluate Bulgaria for your situation

  • Do not infer treatment of an underlying cause without condition- and product-specific evidence.
  • Verify confidentiality, data protection and the identity of the clinically responsible provider.
  • Request an itemised written quotation before travel.
  • Request the visit, monitoring and follow-up schedule in writing.

Compare like with like

Country ranges may describe different products, doses, visits and inclusions. Request itemised current quotations, record each source and retrieval date, and verify the regulatory status of the exact proposal before comparing totals.

Safety & practicalities note

EUBulgaria is an EU member state, but that does not verify a specific provider, product or treatment.
Check current government travel advice, insurance, accessibility and emergency arrangements for your own dates.
Entry requirements vary by nationality and trip length. Check current official Bulgarian guidance before booking.
Request a current written quotation with inclusions, exclusions, cancellation and refund terms.

This note is general information for planning, not legal or medical advice. Confirm entry rules for your nationality before booking.

Your situation, specifically

These conditions are the most relevant for your situation:

An online guide cannot determine candidacy. Ask an independent qualified clinician to review the proposed product, evidence, risks and alternatives before you consent or pay.

Educational information. Outcomes vary by patient; consult a qualified physician.

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information